130 related articles for article (PubMed ID: 38393896)
1. Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.
Vaishnav N; Gonzalez R; Karunungan K; Tyler A; Zheng W; Arias JJ
J Alzheimers Dis; 2024; 98(1):187-195. PubMed ID: 38393896
[TBL] [Abstract][Full Text] [Related]
2. The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer's Biomarker Results to Research Participants.
Erickson CM; Chin NA; Ketchum FB; Eveler ML; Conway CE; Coughlin DM; Clark LR
J Prev Alzheimers Dis; 2024; 11(1):1-6. PubMed ID: 38230711
[TBL] [Abstract][Full Text] [Related]
3. Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.
Gale SA
J Alzheimers Dis; 2024; 99(2):489-492. PubMed ID: 38701152
[TBL] [Abstract][Full Text] [Related]
4. Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.
Ketchum FB; Chin NA; Grill J; Gleason CE; Erickson C; Clark LR; Paulsen JS; Kind AJH
Alzheimers Dement; 2022 Oct; 18(10):1969-1979. PubMed ID: 35213786
[TBL] [Abstract][Full Text] [Related]
5. Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review.
van der Schaar J; Visser LNC; Bouwman FH; Ket JCF; Scheltens P; Bredenoord AL; van der Flier WM
Alzheimers Res Ther; 2022 Feb; 14(1):31. PubMed ID: 35144684
[TBL] [Abstract][Full Text] [Related]
6. Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet.
Arias JJ; Karlawish J
Neurology; 2014 Feb; 82(8):725-9. PubMed ID: 24477112
[TBL] [Abstract][Full Text] [Related]
7. Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials.
Rahman-Filipiak A; Bolton C; Grill JD; Rostamzadeh A; Chin N; Heidebrink J; Getz S; Fowler NR; Rosen A; Lingler J; Wijsman E; Clark L;
Alzheimers Dement; 2023 Sep; 19(9):4270-4275. PubMed ID: 37450489
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects.
Rostamzadeh A; Schwegler C; Gil-Navarro S; Rosende-Roca M; Romotzky V; Ortega G; Canabate P; Moreno M; Schmitz-Luhn B; Boada M; Jessen F; Woopen C
J Alzheimers Dis; 2021; 80(2):601-617. PubMed ID: 33554900
[TBL] [Abstract][Full Text] [Related]
9. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
10. On the personal utility of Alzheimer's disease-related biomarker testing in the research context.
Bunnik EM; Richard E; Milne R; Schermer MHN
J Med Ethics; 2018 Dec; 44(12):830-834. PubMed ID: 30154216
[TBL] [Abstract][Full Text] [Related]
11. Practices and opinions about disclosure of the diagnosis of Alzheimer's disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementia.
Mormont E; Bier JC; Bruffaerts R; Cras P; De Deyn P; Deryck O; Engelborghs S; Petrovic M; Picard G; Segers K; Thiery E; Versijpt J; Hanseeuw B
Acta Neurol Belg; 2020 Oct; 120(5):1157-1163. PubMed ID: 32715405
[TBL] [Abstract][Full Text] [Related]
12. What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.
Ketchum FB; Erickson CM; Chin NA; Gleason CE; Lambrou NH; Benton SF; Clark LR
J Alzheimers Dis; 2022; 87(3):1167-1179. PubMed ID: 35466937
[TBL] [Abstract][Full Text] [Related]
13. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?
Cox CG; Ryan MM; Gillen DL; Grill JD
J Prev Alzheimers Dis; 2021; 8(1):52-58. PubMed ID: 33336225
[TBL] [Abstract][Full Text] [Related]
14. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.
Grill JD; Zhou Y; Elashoff D; Karlawish J
Neurobiol Aging; 2016 Mar; 39():147-53. PubMed ID: 26923411
[TBL] [Abstract][Full Text] [Related]
15. Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.
Bemelmans SA; Tromp K; Bunnik EM; Milne RJ; Badger S; Brayne C; Schermer MH; Richard E
Alzheimers Res Ther; 2016 Nov; 8(1):46. PubMed ID: 27832826
[TBL] [Abstract][Full Text] [Related]
16. Assess the documentation of cognitive tests and biomarkers in electronic health records via natural language processing for Alzheimer's disease and related dementias.
Chen Z; Zhang H; Yang X; Wu S; He X; Xu J; Guo J; Prosperi M; Wang F; Xu H; Chen Y; Hu H; DeKosky ST; Farrer M; Guo Y; Wu Y; Bian J
Int J Med Inform; 2023 Feb; 170():104973. PubMed ID: 36577203
[TBL] [Abstract][Full Text] [Related]
17. Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data.
van der Schaar J; Visser LNC; Ket JCF; Groot C; Pijnenburg YAL; Scheltens P; Bredenoord AL; van den Hoven MA; van der Flier WM
Alzheimers Dement; 2023 Dec; 19(12):5773-5794. PubMed ID: 37496313
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results.
Erickson CM; Chin NA; Ketchum FB; Jonaitis EM; Zuelsdorff ML; Gleason CE; Clark LR
Alzheimer Dis Assoc Disord; 2022 Apr-Jun 01; 36(2):125-132. PubMed ID: 35125399
[TBL] [Abstract][Full Text] [Related]
19. Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society.
Erickson CM; Clark LR; Ketchum FB; Chin NA; Gleason CE; Largent EA
Alzheimers Dement (Amst); 2022; 14(1):e12339. PubMed ID: 36035626
[TBL] [Abstract][Full Text] [Related]
20. Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
Schweda M; Kögel A; Bartels C; Wiltfang J; Schneider A; Schicktanz S
J Alzheimers Dis; 2018; 62(1):145-155. PubMed ID: 29439325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
